FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103178838> ?p ?o ?g. }

• W2103178838 endingPage "1289" @default.
• W2103178838 startingPage "1273" @default.
• W2103178838 abstract "HIV entry and fusion are two steps in the viral life cycle that can be targeted by several classses of antiviral drugs. The discovery of chemokines focused the attention on cellular coreceptors used by the virus for entering within cells, and to the various steps of such processes which are subject to interactions with small molecules. Intense research led to a wide range of effective compounds that are able to inhibit these initial steps of viral replication. All steps in the process of HIV entry into the cell may be targeted by specific compounds that may be developed as novel types of antiretrovirals. Thus, several inhibitors of the gp120 - CD4 interaction have been detected so far (zintevir, FP-21399 and BMS-378806 in clinical trials). Small molecule chemokine receptor antagonists acting as HIV entry inhibitors also were described in the last period, which interact both with the CXCR4 coreceptor (such as AMD3100; AMD3465; ALX40-4C; T22, T134 and T140), or which are antagonist of the CCR5 coreceptor (TAK-779, TAK-220, SCH-C, SCH-D, E913, AK- 602 and NSC 651016 in clinical trials), together with new types of fusion inhibitors possessing the same mechanism of action as enfuvirtide (such as T1249). Recently, a third family of antivirals started to be used clinically (in addition to the reverse transcriptase and protease inhibitors), with the advent of enfuvirtide (T20), the first fusion inhibitor to be approved as an anti-HIV agent. Some of these compounds demonstrated in vitro synergism with other classes of antivirals, offering thus the rationale for their combination in therapies for HIV-infected individuals. Many HIV entry and fusion inhibitors are currently investigated in controlled clinical trials, and there are a number of them that is bioavailable as oral formulations. This is an essential feature for an extended use of these compounds with the purpose of ameliorating adherence of patients to these medications and preventing the development of drug resistance. Keywords: Attachment inhibitors, CCR5, CXCR4, chemokines, chemokine receptor antagonist, fusion inhibitor, HIV" @default.
• W2103178838 created "2016-06-24" @default.
• W2103178838 creator A5012797490 @default.
• W2103178838 creator A5035652477 @default.
• W2103178838 creator A5044171804 @default.
• W2103178838 creator A5079937254 @default.
• W2103178838 date "2007-07-01" @default.
• W2103178838 modified "2023-09-23" @default.
• W2103178838 title "An Update in the Development of HIV Entry Inhibitors" @default.
• W2103178838 cites W1482346540 @default.
• W2103178838 cites W1515745795 @default.
• W2103178838 cites W1525366153 @default.
• W2103178838 cites W1556988007 @default.
• W2103178838 cites W1623426438 @default.
• W2103178838 cites W191242174 @default.
• W2103178838 cites W1926800398 @default.
• W2103178838 cites W1965508366 @default.
• W2103178838 cites W1966015585 @default.
• W2103178838 cites W1966105418 @default.
• W2103178838 cites W1969522561 @default.
• W2103178838 cites W1972939822 @default.
• W2103178838 cites W1974543288 @default.
• W2103178838 cites W1976248745 @default.
• W2103178838 cites W1977566529 @default.
• W2103178838 cites W1979563231 @default.
• W2103178838 cites W1979658483 @default.
• W2103178838 cites W1981471474 @default.
• W2103178838 cites W1984811742 @default.
• W2103178838 cites W1989035987 @default.
• W2103178838 cites W1989172083 @default.
• W2103178838 cites W1991539551 @default.
• W2103178838 cites W1993729293 @default.
• W2103178838 cites W1999048558 @default.
• W2103178838 cites W2000551760 @default.
• W2103178838 cites W2000625719 @default.
• W2103178838 cites W2001383387 @default.
• W2103178838 cites W2001601356 @default.
• W2103178838 cites W2005228785 @default.
• W2103178838 cites W2007851147 @default.
• W2103178838 cites W2008746614 @default.
• W2103178838 cites W2010638326 @default.
• W2103178838 cites W2010870296 @default.
• W2103178838 cites W2015002417 @default.
• W2103178838 cites W2015278021 @default.
• W2103178838 cites W2016168906 @default.
• W2103178838 cites W2016353171 @default.
• W2103178838 cites W2017436619 @default.
• W2103178838 cites W2023270608 @default.
• W2103178838 cites W2023398587 @default.
• W2103178838 cites W2024062147 @default.
• W2103178838 cites W2025430406 @default.
• W2103178838 cites W2026327276 @default.
• W2103178838 cites W2029043718 @default.
• W2103178838 cites W2030648131 @default.
• W2103178838 cites W2030787175 @default.
• W2103178838 cites W2033757712 @default.
• W2103178838 cites W2036656105 @default.
• W2103178838 cites W2038063067 @default.
• W2103178838 cites W2039492946 @default.
• W2103178838 cites W2040506631 @default.
• W2103178838 cites W2041251988 @default.
• W2103178838 cites W2043448829 @default.
• W2103178838 cites W2046999368 @default.
• W2103178838 cites W2049868653 @default.
• W2103178838 cites W2051775752 @default.
• W2103178838 cites W2053163712 @default.
• W2103178838 cites W2053626694 @default.
• W2103178838 cites W2055123316 @default.
• W2103178838 cites W2055903147 @default.
• W2103178838 cites W2056150433 @default.
• W2103178838 cites W2056357424 @default.
• W2103178838 cites W2059015229 @default.
• W2103178838 cites W2067964854 @default.
• W2103178838 cites W2068794941 @default.
• W2103178838 cites W2069711031 @default.
• W2103178838 cites W2072470381 @default.
• W2103178838 cites W2075009216 @default.
• W2103178838 cites W2078758406 @default.
• W2103178838 cites W2079931546 @default.
• W2103178838 cites W2080845610 @default.
• W2103178838 cites W2083612980 @default.
• W2103178838 cites W2084342429 @default.
• W2103178838 cites W2094180923 @default.
• W2103178838 cites W2096451161 @default.
• W2103178838 cites W2096649016 @default.
• W2103178838 cites W2096734949 @default.
• W2103178838 cites W2096950500 @default.
• W2103178838 cites W2097524602 @default.
• W2103178838 cites W2098509726 @default.
• W2103178838 cites W2098781795 @default.
• W2103178838 cites W2101199324 @default.
• W2103178838 cites W2102237910 @default.
• W2103178838 cites W2102732416 @default.
• W2103178838 cites W2102953571 @default.
• W2103178838 cites W2104918497 @default.
• W2103178838 cites W2105789040 @default.
• W2103178838 cites W2107672429 @default.
• W2103178838 cites W2108538162 @default.

• next